MyFinsight

HomeAboutContact
Curious boy with magnifying glass
A worm made of letters APL
A worm made of letters BOA

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2024 MyFinsight. All rights reserved.

XOMA Royalty Corp (XOMAP)

For the quarter ending 2025-06-30, XOMAP made $13,129K in revenue. $9,191K in net income. Net profit margin of 70.01%.

Overview

Revenue
$13,129K
Net Income
$9,191K
Net Profit Margin
70.01%
EPS
$0.44
Unit: Thousand (K) dollars
Revenue Breakdown
    • Affitech Research As-Vabysmo
    • Revenue from contracts with cust...
    • Tovorafenib-Viracta Therapeutics...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
2025-06-30
Total income and revenues13,129
Research and development69
General and administrative7,802
Amortization of intangible assets655
Total operating expenses8,526
Income (loss) from operations4,603
Interest expense3,236
Other income, net7,824
Net income9,191
Earnings per share, basic0.46
Earnings per share, diluted0.44
Weighted average number of shares outstanding, basic12,007,000
Weighted average number of shares outstanding, diluted17,761,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement

DownloadDownload image
Talphera$28K Tovorafenib-Viracta TherapeuticsInc.$1,715K Affitech ResearchAs-Vabysmo$5,758K Aptevo-Ixinity$249K Revenue from contractswith customers$5,025K Income from purchasedreceivables under the cost...$1,743K Income from purchasedreceivables under the eir...$6,007K Revenue recognizedunder...$354K Total income andrevenues$13,129K Income (loss) fromoperations$4,603K Other income, net$7,824K Total operatingexpenses$8,526K Net income$9,191K Interest expense$3,236K Amortization of intangibleassets$655K General andadministrative$7,802K Research and development$69K